Cynthia M Butitta - Net Worth and Insider Trading
Cynthia M Butitta Net Worth
The estimated net worth of Cynthia M Butitta is at least $22 Million dollars as of 2024-12-29. Cynthia M Butitta is the COO of Kite Pharma Inc and owns about 121,567 shares of Kite Pharma Inc (KITE) stock worth over $22 Million. Cynthia M Butitta is also the COO and CFO of MabVax Therapeutics Holdings Inc and owns about 7 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $0. Details can be seen in Cynthia M Butitta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cynthia M Butitta has not made any transactions after 2017-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cynthia M Butitta
Cynthia M Butitta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cynthia M Butitta owns 5 companies in total, including UroGen Pharma Ltd (URGN) , Kite Pharma Inc (KITE) , and MabVax Therapeutics Holdings Inc (MBVXQ) among others .
Click here to see the complete history of Cynthia M Butitta’s form 4 insider trades.
Insider Ownership Summary of Cynthia M Butitta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2019-01-01 | director |
| KITE | Kite Pharma Inc | 2017-10-03 | Chief Operating Officer |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2009-11-18 | COO and CFO |
 | | 2020-11-18 | director |
| | 2022-06-09 | director |
Cynthia M Butitta Latest Holdings Summary
Cynthia M Butitta currently owns a total of 2 stocks. Among these stocks, Cynthia M Butitta owns 121,567 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $22 Million and a weighting of 100%. Cynthia M Butitta also owns 7 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of August 10, 2006, with a value of $0 and a weighting of 0%.
Latest Holdings of Cynthia M Butitta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KITE | Kite Pharma Inc | 2017-09-25 | 121,567 | 179.79 | 21,856,531 |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2006-08-10 | 7 | 0.02 | 0 |
Holding Weightings of Cynthia M Butitta
Cynthia M Butitta Form 4 Trading Tracker
According to the SEC Form 4 filings, Cynthia M Butitta has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 4,228 shares on September 25, 2017, which brought Cynthia M Butitta around $759,602.
According to the SEC Form 4 filings, Cynthia M Butitta has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the acquisition of 1 shares on August 10, 2006, which cost Cynthia M Butitta around $77,350.
Insider Trading History of Cynthia M Butitta
- 1
Cynthia M Butitta Trading Performance
GuruFocus tracks the stock performance after each of Cynthia M Butitta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cynthia M Butitta is 19.49%. GuruFocus also compares Cynthia M Butitta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cynthia M Butitta within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cynthia M Butitta's insider trading performs compared to the benchmark.
Performance of Cynthia M Butitta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.52 | | | | | |
| Relative Return to S&P 500(%) | 7.39 | | | | | |
Cynthia M Butitta Ownership Network
Cynthia M Butitta Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Cynthia M Butitta is the director of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include General Counsel Jason Drew Smith , Chief Medical Officer Mark Schoenberg , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Cynthia M Butitta made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 25,590 shares made by Mark Schoenberg , and a net sale of 15,307 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 0 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,897 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,897 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Cynthia M Butitta Mailing Address
Above is the net worth, insider trading, and ownership report for Cynthia M Butitta. You might contact Cynthia M Butitta via mailing address: 3165 Porter Drive, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
